MarketPulse — Real-Time Financial News & Market Analysis

Latest News

9,799 articles
Mon, Mar 23
The Motley FoolThe Motley Fool··Katie Brockman

Stock Decline Stokes Recession Fears: How to Stress-Test Your Portfolio

As stock prices decline amid recession concerns, investors should stress-test portfolios through diversification, quality focus, and adequate emergency reserves.
IMKTFVSPFFstock volatilityportfolio diversification
BenzingaBenzinga··South Plains Financial, Inc.

South Plains Financial Clears Final Hurdles for BOH Holdings Merger Closing

South Plains Financial and BOH Holdings receive final regulatory and shareholder approvals for merger, closing set for April 1, 2026.
SPFImergerbanking
BenzingaBenzinga··Prnewswire

Lazard Global Fund Maintains 9.85% Distribution Yield With April Payout

Lazard Global Total Return and Income Fund declared $0.15340 monthly distribution with 9.85% annualized yield, consisting mainly of return of capital.
LAZdividendmanaged distribution policy
BenzingaBenzinga··Prnewswire

AllianceBernstein Boosts Payouts on Closed-End Funds Ahead of April Distribution

AllianceBernstein declares April distributions for Global High Income Fund ($AWF) and National Municipal Income Fund ($AFB), signaling continued income-generation strength.
ABdividend announcementclosed-end funds
BenzingaBenzinga··Prnewswire

Columbus McKinnon Maintains Dividend With $0.07 Quarterly Payout

$CMCO declares $0.07 quarterly dividend payable May 11, 2026. Represents continued shareholder capital return commitment from industrial equipment manufacturer.
CMCOdividendquarterly
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Aquestive Faces Securities Fraud Suit Over Anaphylm FDA Misrepresentation

Aquestive Therapeutics faces securities fraud lawsuit after FDA rejected Anaphylm drug, contradicting management's prior "on track" statements; $AQST stock fell 37%.
AQSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Na

AOI Lands $53M AI Datacenter Deal as Hyperscalers Race for 800G Capacity

Applied Optoelectronics secures $53M+ order for 800G datacenter transceivers from major hyperscaler, with additional orders anticipated as AI infrastructure scales globally through 2026 and beyond.
AAOIsupply chaindata center
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Snowflake Faces Securities Fraud Suit as Stock Plunges 18% on Misleading Guidance

Snowflake faces securities fraud suit after 18% stock drop on corrective disclosures regarding consumption patterns and $10B revenue target claims.
SNOWsecurities fraudstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Plug Power Faces Securities Lawsuit Over DOE Funding Claims

Levi & Korsinsky filed class action against Plug Power for alleged false statements on DOE loans and hydrogen projects. Investors can join suit by April 3, 2026.
PLUGsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Inovio Pharmaceuticals Hit with Securities Fraud Suit Over FDA Claims

Law firm Levi & Korsinsky files class action against Inovio Pharmaceuticals for allegedly false statements regarding device manufacturing and FDA pathways from October 2023 to December 2025.
INOsecurities class actionmisrepresentation
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Paysafe Faces Securities Lawsuit Over Allegedly Inadequate Risk Disclosures

Lawsuit alleges Paysafe used generic risk language to mask material operational problems rather than disclosing actual merchant portfolio and banking challenges.
PSFEsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

CHOW Stock Crashes 84% Amid Market Manipulation Fraud Claims

ChowChow Cloud shares plummeted 84.3% after allegations of coordinated market manipulation scheme. Class action lawsuit targets company and underwriter for failing to disclose fraud risks.
CHOWsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Apollo Global Management Faces Securities Fraud Class Action Over Undisclosed Epstein Ties

Apollo Global Management faces securities fraud lawsuit over undisclosed Epstein business dealings. Stock fell 5% as investors explore class action eligibility through May 1, 2026.
APOAPOSAPOpAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Grocery Outlet Faces Securities Fraud Suit Over Concealed Expansion Woes

$GO faces securities fraud suit over concealed weak expansion; stock down 27.9% after announcing 36 store closures and $110M impairment charges.
GOsecurities fraudclass action lawsuit
BenzingaBenzinga··Piero Cingari

Goldman Sachs Raises Oil Price Forecasts, Names 7 Energy Stocks as Winners

Goldman Sachs raises oil price forecasts to $80-$100/barrel for 2026, naming seven energy stocks as winners positioned to benefit from higher crude prices and strong cash flow generation.
CVXFANGCOPCVEOVV+2Permian Basinfree cash flow
The Motley FoolThe Motley Fool··Bram Berkowitz

Trump Tax Cuts May Be Erased by Oil Surge as Energy Costs Threaten 2025 Savings

Trump's projected $750 average tax refunds threatened by oil-driven energy costs adding $740+ annually to household expenses, likely preventing Fed rate cuts in 2025.
GSGSpAGSpCGSpDinflationFederal Reserve
The Motley FoolThe Motley Fool··Neil Rozenbaum

SoFi Stock Looks Undervalued as Growth Trajectory Outpaces Market Price

SoFi Technologies appears undervalued relative to its earnings growth trajectory, presenting a potential buying opportunity for fintech-focused investors.
SOFIfintechstock valuation
The Motley FoolThe Motley Fool··Dave Kovaleski

Vanguard Momentum ETF Defies Market Slump With 27% Annual Gains

Vanguard's $VFMO momentum ETF delivered 3.4% YTD returns and 27% annual gains, substantially outperforming broader indexes while market remains pressured.
MUGEVLRCXVFMOmarket volatilityoutperformance
The Motley FoolThe Motley Fool··Leo Sun

Wedbush Eyes 2026 as AI's Inflection Year, Names $CRWD as Top Pick

Wedbush analyst Dan Ives identifies 2026 as AI's inflection point, naming CrowdStrike as the most compelling play among five recommended stocks.
MSFTAAPLPLTRTSLACRWD+1cloud computingartificial intelligence
The Motley FoolThe Motley Fool··James Brumley

ImmunityBio Surges 11% on First Asian Approval for Bladder Cancer Drug

ImmunityBio stock surged 11.2% after Macau approved its bladder cancer drug Anktiva, marking the company's first Asian regulatory victory and potential gateway for regional expansion.
IBRXAsia-Pacific expansionbladder cancer